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Abstract
Introduction: Headache is a chronic pain that is challenging to properly assess in clinical
practice, as it is based almost entirely on the ability of the clinician and patient to
communicate. This communication is based on pain scale tools. To assess patients’
disability and pain intensity, the selected organization uses the Migraine Disability
Assessment (MIDAS) screening tool. Pain intensity is measured with a Numeric Pain Scale
within the MIDAS. Measuring chronic headache pain accurately, while using a very
subjective and inadequate pain scale to measure chronic pain was an issue. The literature
review supported replacing the Numeric Pain Scale with the Mankoski within the MIDAS
screening tool. The DNP scholarly project aimed to answer the question: Does
implementation of the standardized and descriptive headache assessment tool, the
Mankoski, at a Neurology Clinic in a Midwestern City improve the accuracy of the MIDAS
screening tool?
Objectives: The use of an evidence-based pain assessment tool to improve the assessment
of pain for all patients. To focus solely on patients with headaches who come into a
Neurology Clinic in a Midwestern city and to screen all headache patients with the MIDAS
screening tool.
Methods: The quality improvement project used a pre and post data comparison. The pre
data from 2018 had the pain portion rated on the Numeric Pain Scale and the post –data
from 2019 had the pain portion rated with the Mankoski pain scale. Collected data included
age, sex, diagnosis, MIDAS score, and pain scale score. The inclusion criteria were all
adults over 18 years of age, who presented with any type of headache. Exclusion criteria
were headache red flags, such as: sudden acute headache that has a new onset, worsening
pain, and patients under 18 years of age.
Results: A total of 107 patient encounters were included in the collected data. In 2018, 51
patients presented with a diagnosis of headache. In 2019, 56 patients presented with a
diagnosis of headache. The pain and functional status were correlated using a Pearson’s
correlation. The data from these ordinal level scales were treated as interval level data. The
project measured the correlation of MIDAS and the Numerical pain scale and the correlation
of MIDAS and the Mankoski scale. In 2018, the correlation between MIDAS and numerical
pain scale was 0.11177 (p=0.4349). In 2019, the correlation between the MIDAS and
Mankoski was 0.50360 (p=0.0001). The Mankoski clearly better assesses the association
between function and pain.
Conclusions: According to this quality improvement project results, chronic headache pain
is measured more accurately with the Mankoski pain scale. As a result patient and provider
have a better mutual understanding of the condition and a better treatment plan.
Implications: Implication for practice includes standardizing screening of headache
patients, by administering a revised MIDAS screening tool to all headache patients on each
visit.
Key words: Headache assessment, pain assessment tools, Numeric pain scale, Mankoski
pain scale, MIDAS and pain, numeric pain scale reliability, Mankoski pain scale reliability,
migraine headache, Mankoski vs. Numeric pain scale.
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Evidence-Based Intervention to Improve Assessment of Headache Pain and Its Functional
Capacity
Introduction
Chronic pain is a major public health concern and the chief complaint among many
people seeking medical attention. One of the most persistent chronic pain events is the
headache. In the adult population, headache disorders have been reported to be among the
ten most disabling conditions on the World Health Organization’s ranking of causes of
disability (Benz et al., 2018). A headache can occur in any part of the head. The patient may
experience sharp pain, a throbbing sensation, or a dull ache that develops gradually or
suddenly.
In clinical practice, the headache is a unique condition as it is based almost entirely
on the ability of the clinician and patient to effectively communicate and understand one
another (Cady, Farmer, Beach, & Tarrasch, 2008). All therapeutic decisions are then based
upon this communication. However, the ability of a patient to describe a headache in an
objective manner is limited. Thus, communication is often based on pain scale tools. Pain
scales are meant to facilitate communication between healthcare providers and clients. Clear
communication is necessary in order to help the health care provider prescribe correct
medicine in the correct dosages to treat the headache (Douglas, Randleman, DeLane, &
Palmer, 2014). Headache specialists need to plan accordingly and adjust their plans if
necessary. Effective communication may also limit the number of Emergency Department
visits due to the failure of the treatment plans (Cady et al., 2018). This is why using an
accurate pain scale is so vital.
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Several types of pain assessment scales have been developed in order to measure the
intensity of pain properly. Pain scales are subjective, but the ultimate goal is to make certain
that they are as objective as possible so that communication is clear between the patient and
the health care professional (Manworren & Stinson, 2016).
As mentioned above, headache is a chronic pain that is challenging to properly
assess clinical practice. During the Doctor of Nursing Practice (DNP) project organizational
assessment, a Neurology Clinic in a Midwestern City was found to lack a descriptive and
more objective pain scale to assess chronic headache pain properly. The organization uses
the Migraine Disability Assessment (MIDAS) screening tool to assess patient disability as
well as headache pain. At the time of the organizational assessment, the MIDAS included
the Numeric Pain Scale. The Numeric Pain Scale is not particularly patients descriptive of
the pain level, which created a challenge when properly assessing patients and when
communicating between practitioner and patient. The solution to the problem is the
Mankoski scale that was identified during the literature review. This was introduced and
implemented as an evidence-based practice change.
The Mankoski pain scale uses both words and numbers in order to describe the pain
ratings from “0” to “10”, with each number on the line having a description (Whelan, 2003).
For example, “0” is “pain free, no medication needed”; “2” is “minor annoyance -occasional
strong twinges, No medication needed”; “6” is “can’t be ignored for any length but you
[one] can still go to work and participate in social activities, Stronger painkillers
(Codeine,Vicodin) reduce pain for 3-4 hours;” and “10” is “Unconscious. Pain makes you
pass out. Strongest painkillers are only partially effective” (Appendix A). This allows the
7
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patient to give a more complete picture, of his/her pain intensity by using words instead of
just numbers. In this way a patient can paint a clear picture of his or her pain that can be
better understood by the provider (Herford, Cicciu, Maiorana, & Boyne, 2010).
Based on the structure of the Mankoski scale, the DNP student predicted that
patients’ ratings would more accurately describe pain, improve patient provider
communication, and create better headache pain management. Replacing the Numeric Pain
Scale used on the MIDAS with the Mankoski was supported by its demonstrated reliability
and validity, as well as patient preference (Douglas et al., 2014). Therefore, the literature
supported this practice change.
The purpose of this quality improvement project was to implement a new more
descriptive pain scale that would replace the Numerical Pain Scale that has been used within
the MIDAS screening tool to improve the accuracy of MIDAS scores, and ultimately to
better manage patients’ headaches by improving patient provider communication of pain
level.
Assessment of the Organization
The Neurology Clinic in a Midwestern city is located in a non-profit health care
system serving the surrounding communities. The organization is a Catholic, faith-based
setting that honors the sacredness and dignity of every person. In addition, this Neurology
Clinic provides compassionate care, award-winning expertise, and the latest technology.
The organization serves the community with the spirit of the Gospel for compassionate and
transforming healing. At the clinic, everything the organization does is rooted within their
heritage as a faith-based organization. The organization strongly values the dignity of
community members and commits to serve the vulnerable and poor. The organization
8
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communicates openly, honestly, respectfully, and directly, and adheres to guiding behaviors
of accountability, trustworthiness, and trusting good intentions (XXX,2018).
Framework for Assessment
The Burke and Litwin Model of Organizational Performance and Change (Burke &
Litwin, 1992) framework was used to guide the organizational assessment for this practice
evaluation project at the Headache Clinic within the Neurology Clinic of a Midwestern city.
This model was an appropriate tool to use within the context of the phenomenon of interest:
to improve headache patients’ outcomes. This model also helped provide a clear picture for
assessing the organization’s team effectiveness, culture, leadership, and also how change
can be influenced (Burke & Litwin, 1992). Finally, this model was very helpful to identify
the scholarly project work that could meet the organization’s needs. The Burke-Litwin
Model has a multidimensional approach to assess the effects of concepts and the
relationship between them in order to determine an organization’s ability to perform change.
The Burke-Litwin Model, also known as A Causal Model of Organizational
Performance and Change, contains 12 different organizational variables and development
tools that interact to drive change (Burke & Litwin, 1992). This model uses arrows to
describe the influence of the variables on each other. All 12 variables (Appendix B) are
categorized into two factor groups, transformational and transactional (Burke & Litwin,
1992). The arrows are directed both ways and suggest organizational performance, the
organization’s impacts on the external environment, and how the organization is affected by
the external environment (Burke & Litwin, 1992). Transformational factors are affected by
interaction with environmental forces; these elements are core to an organization’s
performance and delivery of results. The transactional factors are the elements of an
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organization that are more easily changed and have less impact on the outcome (Burke &
Litwin, 1992).
The transformational elements of this model include external environment,
leadership, mission and strategy, organizational culture, and individual and organizational
performance. Transformational change is associated with leadership on the top portion of
the model (Appendix C).
The model’s transactional elements are the management practices, systems,
structure, work unit climate, tasks, individual skills, motivation, individual needs, values,
and individual and organizational performance (Appendix D). These elements are in the
lower portion of the model. This type of change is within the purview of management.
Stakeholders
Moran, Burson, and Conrad (2017) define key stakeholders as individuals or groups
who are an important part of the DNP project or implementation outcome or who have
influence on the success of a project and its outcome. Stakeholders to the evaluation and
outcome of implementing the descriptive pain scale and screening tool for the headache
population include: healthcare providers, physicians, nurse practitioners, physician
assistants, registered nurses (RNs), unit leadership, managers, supervisors, medical
assistants (MAs), and patients.
The process for assessing headache pain at the clinic follows a consistent pattern.
Medical assistants place the patients in a room, collect vital signs, record patient complaints,
and guide the patient on filling out the MIDAS screening tool. Registered nurses interview
the patients to gather information regarding their current treatment, what medication refills
they need, their physical state, and the reason for their office visit. Health care providers
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analyze the pain scale and MIDAS score relationship, evaluate the last treatment plan
outcome, and determine if the current treatment plan is successful or if it needs to be
readjusted. Patients receive the screening tools and provide feedback regarding the pain and
the treatment they have received.
SWOT
An analysis of internal strengths, weaknesses, external opportunities, and threats
(SWOT) of the Headache Clinic organization was performed (Culp, Eastwood, Turner,
Goodman, & Ricketts, 2016). The goal of performing a SWOT analysis on an organization
is to determine the key factors that may impact the change the organization will face within
the context of the phenomenon of interest.
Strengths. The Headache Clinic has many strengths (See SWOT analysis in Appendix E).
The clinic focuses on collaborative, coordinated, patient-centered care. The Headache Clinic
is part of a large, national health care system. The clinic supports care improvement
initiatives and is one of only a few subspecialty clinics that exists in the Midwestern city.
Leaders are motivated and staff is collaborative about patients’ positive outcomes.
According to the DNP student observation, Register Nurses (RNs) and Medical assistants
(MAs) take time to answer patients’ questions, educate them as needed, and assist them with
completing the MIDAS assessment tool. The staff takes time with all patients to build
trusting relationships, make them feel important, and help them become a part of the clinic.
The clinic staff is also very supportive and open to the change and improvement of the
MIDAS assessment. LEAN process meetings happen weekly during which the staff
discusses problems with processes to improve the quality of patient outcomes. Also, the
organization has an established professional staff with low turnover and long tenure.
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Weaknesses. An identified weakness of the Headache Clinic is the lack of a standardized
process for handling the MIDAS screening tool. Variability exists among providers and,
depending on the provider, not all the patients get the MIDAS screening with their follow up
visits. Also, the clinic lacks formalized patient education regarding the pain scale, which
leads to high MIDAS scores. An additional weakness of the organization is a high turnover
of MAs. The high turnover of MAs makes it challenging to establish a standardized practice,
because new staff constantly need training on the organization’s established procedure.
Opportunities. The Headache Clinic has the opportunity to improve MIDAS scoring and
have a standard procedure for all headache patients. It has the opportunity for additional
evidence-based interventions regarding how to decrease MIDAS scores with a more
descriptive pain scale and more patient education. One key opportunity is that a descriptive
pain scale may influence and increase patient satisfaction scores, as a result of more
effective pain management.
Threats. Unexpected staff change is a threat, which could lead to poor cooperation and the
perception of extra workload. Also, patients' noncompliance and non-collaboration
lengthens the time it takes to complete the MIDAS screening tool and receive a descriptive
pain assessment. Other possible threats include timely approval by the organization’s
Internal Review Board (IRB), imbedding the assessment scale within the electronic health
record (EHR), and severe weather hazards that cause patient cancelations and no shows.
Clinical Practice Question
The identified clinical problem is related to chronic headache assessment and the
standards of care for screening patients. In order to solve this problem, the quality
improvement intervention addressed the following clinical question: Does implementation
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of standardized and descriptive headache assessment tool, such as the Mankoski, at a
Neurology Clinic in a Midwestern city improve the accuracy of MIDAS screening and
practice outcomes for headache patients? In order to understand the best way to approach
this problem, a literature review was conducted.
Review of the Literature
Search Methods
On the initial and the additional search methods the Preferred Reporting Items for
Systematic Reviews and Meta-Analyses (PRISMA) guideline served as the framework for
this review (Moher, Liberati, Tetzlaff, Altman, & PRISMA Group, 2009). A comprehensive
electronic search was conducted in the electronic databases of CINAHL, PubMed,
ScienceDirect and Cochrane (Appendix F). For this literature review, the inclusion criteria
for published manuscripts included: (a) English language, (b) published between 2005 and
2018, (c) intervention studies where any pain scale was included, (d) manuscripts that
compared two or more pain scales, and (e) any systematic review or meta-analysis that
identified the pain scales that were used.
Search terms for articles included the following:
•

Headache Assessment and Numeric Pain Scale and Mankoski Pain Scale

•

Headache Assessment and Mankoski Pain Scale and MIDAS

•

Headache Assessment and Mankoski Pain Scale

•

Mankoski Pain Scale and Numeric Pain Rating Scale Reliability

•

Numeric Pain Rating Scale Reliability and Headache Assessment

•

Headache Assessment and Migraine Headaches and Numeric Pain Rating Scale
Reliability
13
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•

Mankoski Pain Scale

•

Additional search -Mankoski vs. Numeric pain scale

After looking closely at the problem and literature it was clear that there were not many
studies on the Mankoski pain scale, therefore, an additional search was made to determine
what other pain scales were used, in general.
PRISMA
The initial search using these keywords in CINAHL, PubMed, Cochrane, and
ScienceDirect yielded 346 reviews, and an additional search identified two systematic
reviews (Appendix F). Each review was screened using inclusion and exclusion criteria
according to PRISMA criteria (Moher et al., 2009).
A review of titles and abstracts resulted in removing 206 articles. In addition, 68 duplicate
articles were excluded. Also, 27 articles used duplicate datasets. This caused 301 articles to
be removed. Of the remaining 47 (including 2 studies from the additional search), 24 articles
were excluded due to being unsatisfactory for the purposes of this literature review; they
discussed treatment options. The final 23 articles were reviewed, and the strongest 10
studies were included in the literature review.
Additional Inclusion and Exclusion Criteria
Population. Studies were included if samples represented populations aged 18 years
and older and consisted of patients with chronic pain due to a chronic medical condition.
The most useful studies were the studies comparing pain scales. Most of the studies
involved testing different pain scales to see how the patients answered (Cheatham, Kolber,
Mokha, & Hanney, 2018). Some of the studies identified attempted to test the ability of
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patients to live with their chronic headaches. One article compared pain assessments tools
(Manworren & Stinson, 2016).
Intervention. Intervention studies were included based on the pain scale used or use
of the MIDAS.
Comparison. Studies were included if they compared pain scales.
Study Characteristics
The studies examined patients with chronic pain and used pain scales as a way of
evaluating the patients. The subjects were suffering from different types of chronic pain;
however, the chronic pain was not necessarily headache or migraine pain. The pain scale
studies either compared pain scales to other pain scales or used test-retest correlations in
order to evaluate the reliability of the pain scales.
Summary of the Results
The strongest ten articles that met the inclusion criteria were used (Appendix G).
There are two studies by Benz (2017; 2018) that focus on the MIDAS assessment tool. One
of them is an intervention and the other is a comparison study (Benz et al., 2017; Benz et al.,
2018). The eight remaining studies are comparative. There are two systematic reviews, one
randomized control trial(RCT), and the others are descriptive or instrumentation studies. One
study used just the numeric pain scale, and one used just the Mankoski. The systematic
review and descriptive studies primarily used numeric and Visual Analog Scale (VAS). The
study by Douglas (2014) used four pain scales that included Mankoski, Numerical, FACES
and VAS.
Scales to Measure Pain

15
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This section of the paper will review the five most used pain scales in the literature
and practice. One of the most popular pain scales is the Numeric Pain scale. This is what the
identified organization is currently using. Cheatham et al. (2018) suggest that the Numeric
Pain scale is the easiest for a patient to understand. The pain scale is a single 11-point
numeric scale. Higher scores indicate greater pain intensity. Patients are asked to rate their
pain on a 0-10 scale with “0” being no pain and “10” the worst. Unfortunately, the numeric
pain scale can be highly subjective. Studies have shown that patients with chronic pain found
this type of scale inadequate in capturing the complex nature of the pain experience (Hawker,
Mian, Kendzerska, & French, 2011). Patients may attempt to either minimize or exaggerate
the pain depending on various factors including culture, gender and pain history (Hawker et
al., 2011).
Another pain scale that has been used is the Visual Analog scale (VAS). It is a
continuous scale comprised of horizontal or vertical lines usually 10 centimeters (100 mm) in
length anchored at each end by two descriptors. At one end, the descriptor is “no pain.” At
the other end, the descriptor is “pain as bad as it could be” or “worst imaginable pain.”
Usually the patient is asked to place a mark on the line, and the distance from the “no pain”
end is measured in millimeters. A higher score indicates greater pain intensity. Zero to four
millimeters would indicate no pain, and 100 mm would indicate severe pain as defined by the
patient. Its usefulness in the setting of chronic pain is challenging since patients must
quantify the pain intensity. The VAS requires patient education and supervision and has been
found difficult to understand. Also, the VAS is limited by ceiling effects. This often leaves
patients with no ability to quantify worsening pain (Gonzalez-Fernandez et al., 2014).
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The FACES pain scale is a pain scale that was created with and for children to help
them communicate better. It is used around the world for any patients who are older than
three years of age (Mandysova, Nedvedova, & Ehler,2017). It is not limited to use with
children and has been used for patients through the lifespan who have learning difficulties or
poor language skills. The scale shows a series of faces. The happy face represents “0” which
is interpreted as "no hurt." The crying face represents “10” which is interpreted as "hurts the
most." To use the scale properly, patients must understand how to use the scale and choose
the face that best illustrates the pain that they are experiencing. There are numbers on the
scale, so the health care professional can rate the pain based on the face that is chosen. Yet,
there is limited evidence for its validity. Also, the scale does not consider cultural and ethnic
differences in facial expressions (Mandysova et al., 2017).
The Mankoski Pain Scale was developed by Andrea Mankoski, a patient who
suffered from endometriosis. She identified descriptors alongside the numbers 0 to 10 to
assist in recounting her pain to her physicians (Whelan, 2003). The pain scale uses both
words and numbers in order to describe the pain ratings from “0” to “10” and each number
on the line has a description. Where “0” is “pain free, no medication needed”; ”2” is “minor
annoyance -occasional strong twinges, No medication needed”; “6” is “can’t be ignored for
any length but you[one] can still go to work and participate in social activities, Stronger
painkillers (Codeine,Vicodin) reduce pain for 3-4 hours;” and “10” is “Unconscious. Pain
makes you pass out. Strongest painkillers are only partially effective” (Appendix A). This
allows the patient to give a more complete picture, of his/her pain intensity by using words
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instead of just numbers. In this way a patient can paint a clear picture of his or her pain that
can be better understood by the provider (Herford et al., 2010). Douglas et al.(2014) studied
the use of the Mankoski Pain Scale with veterans. They found that the scale was preferred
by the subjects and it demonstrated test–retest reliability of (r =0.69, p < .001)
In addition to assessing the level of pain, evaluating the effects of pain on a person’s
functioning is extremely important (Benz et al., 2017). The Migraine Disability Assessment
(MIDAS) questionnaire helps clinicians assess the impact of a headache and helps to
determine the best treatment option (Appendix H). It is a comprehensive functional scale
based on long-term effects of the headache. It is used to quantify the disability associated
with headaches over a three-month time frame and to determine how severely migraines
affect a patient's life (Zandifar et al., 2014).
It consists of two independent parts. Part one consists of five questions (Stewart,
Lipton, Dowson, & Sawyer, 2001). Patients are asked questions about how often their
headaches limited their ability to participate in activities. For example, one might be asked:
“how many days have you missed work or school because of a headache? ” or “How many
days did you miss leisure or social activities because of your headaches?” A total score is
calculated. There are two additional MIDAS questions (A and B) to collect information on
the frequency of headaches and the intensity of the headache pain. These are not scored in
the MIDAS Questionnaire but are included to provide the provider with clinically relevant
information that may aid in treatment and management decisions. The MIDAS asks, “How
many days have you had a headache? and "on average, how painful were the headaches? For
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the latter question, the MIDAS uses the Numeric Pain Scale of 0-10 with “0” being no pain
and “10” being the most painful.” MIDAS is theoretically better for communicating pain
between the patient and the health care provider due to the fact that it incorporates
functionality into the assessment. According to Stewart et al. (2001) the MIDAS has a
strong test-retest reliability of 0.8 as an assessment tool in health care delivery and clinical
practice in the United States and United Kingdom. It is suited uniquely to the headache
sufferer and is the most comprehensive pain test because it has many questions; however, it
is not ideal for an immediate pain assessment (Zandifar et al., 2014).
Even though the Numeric Pain Scale has been used more frequently, the Mankoski
pain scale has better detail. Douglas et al. (2014) suggest that patients who have chronic
pain are inclined to rate their pain with a shifting baseline, thus minimizing their pain, while
those with acute pain overstate their pain. For this reason, this more descriptive scale may
be more efficacious to include on the MIDAS assessment (Douglas et al., 2014).
Comparison of Scales. Douglas et al. (2014) did the most useful study for the
purposes of this project. They compared all four pain scales described above. The research
by Douglas et al. (2014) compared the pain scales using a sample of 200 veterans (female
n=11 and male n=189). The hypotheses were (a) a significantly higher number of veterans
would identify preference for the Mankoski pain scale when compared with the three other
scales, (b) the Mankoski pain scale is a reliable pain measurement tool, and (c) the
Mankoski Pain Scale is a valid pain measurement tool. Four pain scales (Numeric Pain
Scale, Visual Analog Scale, FACES, and Mankoski) were administered to each veteran. The
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scales were given to the entire sample in random order to eliminate possible confounds
caused by administration of all measures in a specific order. The veterans were asked about
their preference for describing their pain. A majority of the sample preferred the use of the
Mankoski pain scale followed by the Numeric Pain Scale. The findings of Douglas et al.
indicate that the Mankoski pain scale is a reliable and valid instrument for assessment of
pain for veterans. With respect to validity of the Mankoski as a measure of pain, the scale
correlated very well with the Numeric Pain Scale (r = .84, p < .001), Visual Analog (r =.83,
p < .001), and FACES (r=.78, p < .001) scales. Overall, these correlations were moderate to
high; and the highest correlation was found with the Numeric Pain Scale. The test -retest
reliability of the Mankoski Pain Scale was moderate (r= .69, p < .001), and comparable to
the test–retest reliabilities for the Numeric Pain Scale (r=.68, p < .001), Visual Analog
(r=.70,p < .001), and FACES (r=.59, p < .001) scales. One outcome of the research study
was patients and providers preferred using the Mankoski pain scale over all others.
Evidence to Be Used for Project
Headache is a chronic pain that is challenging to properly assess in clinical practice.
The organization uses the MIDAS screening tool to assess patient disability as well as
headache pain. At the time the DNP project was conducted, the MIDAS included the
Numeric Pain Scale, which is not as descriptive of pain levels as the Mankoski scale. Based
on the structure of the Mankoski scale, patient ratings more accurately describe pain and
improve patient provider communication for better headache pain management. Replacing
the Numeric Pain Scale on the MIDAS with the Mankoski scale is supported by its
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demonstrated reliability and validity, as well as patient preference (Douglas et al., 2014).
Therefore, the literature used by this project supported this practice change.
Implementation Conceptual Model
To have a successful implementation and sustainable project, the Promoting Action
on Research Implementation (PARiHS) framework was used to guide the quality
improvement implementation of the Mankoski pain scale at the Headache Clinic. The
framework was developed in 1998. Its purpose was to provide a checklist for successful
implementation of evidence-based research into practice. It is used less in terms of
phenomenon and more in terms of defining the evidence (Kitson, Harvey, & McCormack,
1998). The framework consists of three elements that are the key components of the
framework. These are evidence, context, and facilitation. For a successful project outcome
and implementation each element is vital. High evidence, high context, and high facilitation
are the key determinants of a successful implementation (Kitson et al., 1998).
Evidence. According to Kitson et al. (1998) evidence is the combination of research,
clinical expertise, and patient choice. The research evidence for chronic pain suggests a
more descriptive, comparative pain scale is preferred by patients and clinicians. In addition,
this scale improved patient outcomes.
Context. Context is defined as the environment or setting where the proposed
change will occur (Kitson et al., 1998). As this issue was identified during the process of
organizational assessment, the culture of the organization clearly values quality
improvement and evidence-based patient centered care.
This is the problem that the clinic identified; the organization wanted to have a better
measurement of pain, because they believed it would make for better patient outcomes. The
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organization knew that the implementation of the Mankoski pain scale would not be a major
change in terms of workflow and could be incorporated very easily within the assessment
process. This clinic had leaders (the physician, the nurse practitioner and a nurse) who were
supportive of this change to improve patient outcomes. In addition, improved patient care
and satisfaction are essential goals of the large hospital organization.
Facilitation. The definition of facilitation by Kitson et al. (1998) states that good
facilitation is vital to the success or failure of the implementation of research into practice.
The DNP student served in the facilitator role and was alert to eliminate any barriers that
were detected. The possible barrier that was identified during the organizational assessment
was staff perception of increased workloads. The DNP student educated staff carefully and
was open to any staff concerns to eliminate possible barriers.
Project Plan
The purpose of this Doctor of Nursing Practice (DNP) scholarly project was to
improve the quality of the practice by improving the accuracy of the MIDAS score,
particularly the pain intensity portion of the screening, by replacing the Numeric Pain Scale
with the Mankoski. The second purpose was to standardize the workflow of visits for
patients with headache as a diagnosis, so that every patient is screened with the MIDAS
screening tool.
Objectives
Objectives of this DNP project were aimed at implementing the new pain scale
within the MIDAS screening tool by replacing the Numeric Pain Scale. This included staff
education and collaboration. Below are the objectives of the project.
1. Develop the partnership prior to implementation by January 20, 2019.
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2. Educate the Headache Clinic Physician/neurologist, RN and MA on Mankoski pain
assessment tool that replaces Numerical Pain Scale within MIDAS by January 30th,
2019.
3. Implement the Mankoski, the evidenced based descriptive pain scale, by/on February
10th, 2019.
4. Embed Mankoski scale into EHR to be used with MIDAS screening.
5. Print and laminate two copies of the Mankoski pain scale to place in the patient
rooms #102 and #103 by February 10th, 2019.
6. Collect weekly audit from each patient visit for 4-5 weeks, starting after February
13th, 2019.
7. Collect data from same 4-5 weeks from 1 year prior to this data collection after
February 10th, 2019.
8. Use a brief staff questionnaire (Appendix I) to evaluate the project implementation
process by March 21st, 2019.
9. Develop the final data report to evaluate how well the project outcome, purpose and
clinical questions are met by March 23rd.
10. Distribute the workflow to a key stakeholder by March 23rd, 2019.
11. Develop a sustainability plan by March 25th, 2019.
Type of Project
This DNP project is a quality improvement project that focuses on transitioning the
best evidence-based patient care into the current practice. Quality improvement is defined as
a “systematic and continuous process that leads to measurable improvement in health care
services and the health status of targeted groups” (Health Resources and Services
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Administration [HRSA], 2011, p.1). The purpose of this quality improvement project was to
implement a new more descriptive pain scale (the Mankoski) by replacing the Numerical
Pain Scale that was used within the MIDAS screening tool in order to improve the accuracy
of MIDAS scores and, ultimately, to better manage patients’ headaches.
Design for the Evidence-based Initiative
This project is a quality improvement project focused on assessing patient pain
intensity pre/post tool implementation to validate the Mankoski pain scale screening tool
effectiveness and improving patients’ outcome by standardizing the process of assessing
pain. The proposed change will support pain screening using the Migraine Disability
Assessment (MIDAS), giving patients clear instructions to describe their level of pain, and
ultimately improving the accuracy of the MIDAS assessment to avoid ineffective, overmedicated, or under medicated treatment.
Setting
The setting for the DNP scholarly project is in the Headache Clinic within
Neurology Clinic at one of two of the largest and well-known hospitals in a Midwestern
city. The implementation took place in general Neurology Clinic #1 that consists of one
neurologist, one RN, one MA, and a social worker. In one year, there are 3,225 patient
encounters generated. The DNP student and DNP project chair advisor met with the
organization’s representative to get initial approval of the project idea and verbal
confirmation of proceeding with the project.
Participants
The target population of the DNP scholarly project implementation is headache
patients that are currently seen at the clinic. Also, providers, nurses and MAs are part of the
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target in regard to standardizing workflow and making sure each patient is screened with the
MIDAS and Mankoski consistently. The inclusion criteria for the project are all adult
patients over 18 years of age who present with any type of headache. The exclusion criteria
include red flags for a mass or stroke or sudden acute headache that has a new onset and
sudden and worsening pain, and any patient under 18 years of age.
Model Guiding Implementation
As an Implementation Model for this DNP project the Kotter’s Eight Step Change
Model served as the guiding framework. This model has been used for four decades and
promotes the success of practice change in many organizations and projects (Appendix J).
Kotter created this model after observing more than 100 companies attempt transformation
(Kotter, 1996). In response to his observations, he identified three phases: creating climate
for change, engaging and enabling the organization, and implementing and sustaining for
change. Each phase has steps that total eight steps. These are necessary for a successful
change in an organization (Kotter, 1996). The eight element steps are: create a sense of
urgency, create a coalition, create a vision, communicate the vision, empower action, create
quick wins, build on the change, make it stick. This DNP project is adopting steps 4 through
8: empower action, create quick wins, build on the change, and make it stick.
Implementation Steps and Strategies
Kotter's 8 Step Model was the ideal fit to this project in order to ensure that the
clinical question, purpose, and objectives of the DNP project are addressed in the timeline of
the project.
Engaging and Enabling the Organization. This is the second phase of the Kotter’s
8 Step Change. This phase consists of three steps.
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•

Communicate the vision: Education for the DNP scholarly project was provided
the week of January 17, 2019. The activities included:
§

Educate Physician, RN, MA on Mankoski pain scale.

§

Educate the staff on the process: introduce RN and MA to using the scale,
rooming the patient with EHR open or with printed paper form of MIDAS
screening questionnaire.

§

Replace the (B) part of the questionnaire (the 0-10 Numerical Pain Scale)
with the handheld laminated Mankoski 0-10 pain scale. Use this to ask
patients to rate their pain.

§
•

MA or RN document the result on the EHR.

Empower action: By February 2019, the Mankoski scale will be incorporated into
an EHR: two or more copies of Mankoski scale will be laminated and placed in two
main patient rooms. A staff discussion occurred to cover any workflow issues.
Possible challenges and barriers were addressed and cleared.

•

Create Quick Wins: Every week after February 2019, feedback about
implementation discussed and all questions were answered. This encouraged the
staff to build on success to improve the practice outcome.

Implementing and Sustaining for Change. The third phase of the model is implementing
and sustaining for change (Kotter International, 2017).
•

Building on the change: After data collection was completed and statistical analysis
of correlation between MIDAS and pain tools was completed the final report was
created.the final report was communicated at the departmentwide meeting on March
22nd, 2019 (Appendix L).
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•

Make it stick: The quality improvement project demonstrated success since the
analysis showed the Mankoski clearly better assessed the relationship between
function and pain. The rest of the clinic was interested on implementing this practice
change as well. The implementation was piloted in only one of the clinics in the
department. After an introduction at the department meeting, the remainder of
Neurology department was interested in utilizing the Mankoski pain scale to assess
the chronic pain. It is possible that a new DNP student could carry on the project
from a slightly different perspective beginning April 1, 2019.

Measures
The data collected included the patient’s age, sex, diagnosis, MIDAS score, and pain
scale score. Depending on whether data were derived from early 2018 or early 2019, the
pain scale will be either the Numeric Pain Scale (2018) or Mankoski Pain scale (2019).
Data Collection Procedures
The DNP student collected data through a retrospective chart review. In the record,
two separate numbers are recorded from the MIDAS screening tool. The first number is the
sum of the five MIDAS questions. The second number is the pain intensity scale. For data
collected from early 2018, this number was from the Numeric Pain Scale. Following the
implementation of this project, this number was replaced with the Mankoski Pain Scale.
The DNP student collected post-implementation data weekly at the site from
patients’ EHR chart. Data were collected from the same time frame in the past year. The
approximate projected sample size aimed at100 patients. Collected data were stored on a
password protected Excel file at the clinical site.
Resources and Budget
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The resources for this DNP scholarly project included the DNP student who served
as the project manager, the Headache Clinic neurologist, site mentor family nurse
practitioner (FNP), RN, and MA. The other resources included electronic devices, such as a
computer to print the screening tool and laminator machine to laminate the pain scale. The
DNP student donated time and estimated the cost at $30.00 per hour. The DNP student
included time spent completing the literature review and organizational assessment, as well
as implementing the project. The DNP student donated approximately 10 hours towards
educating staff about proper administration and scoring the results into the EHR. The DNP
time came to a total of 5o hours. All the staff involved within this DNP scholarly project
used there employed time as part of their role and responsibilities (Appendix L,
Glassdoor.com, 2017). Staff time included setting up a meeting/training during “lunch and
learn time” for 30 minutes two times during the week of December 17th, 2018. The
Neurology manager’s time is also included as an in-kind donation. The team included the
Neurology Physician (Site Lead), RN, MA and Statistician.
Methods
The quality improvement project used pre and post data comparison. Data were
collected from the EHR. In the record two separate numbers are recorded from the MIDAS
screening tool. The first number includes the sum of the five MIDAS function questions.
The second number is the pain intensity portion. At the beginning of the project in early
2019, the revised MIDAS was incorporated into the workflow of the practice. The
Headache Clinic practice team was oriented to the revised MIDAS. Patients were screened
with the revised MIDAS tool with the help of the staff person who roomed the patient.
After the tool was marked the rooming staff person entered the scores into the EHR. Data
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were gathered from the EHR for two time periods. Post implementation data were collected
during the 4-6 weeks after the new tool was incorporated into the practice. The same 4-6
weeks from one-year prior (2018) was used to collect data for the pre-implementation
comparison. Data were placed in an Excel file, on the internal site drive. Collected data
included age, sex, diagnosis, MIDAS score, and pain scale score. The data from 2018 had
the pain portion rated on the Numeric Pain Scale and the 2019 data had the pain portion
rated on the Mankoski pain scale. Data collection in 2019 occurred weekly at the site in
person; data from 2018 was accessed according to the hospital guidelines for archival data.
Data were de-identified and entered into a password protected Excel file. The inclusion
criteria were all adults over 18 years of age, who presented with any type of headache.
Exclusion criteria were headache red flags: sudden acute headache that has a new onset,
sudden and worsening pain, patients under 18 years of age.
Analysis
Data were analyzed using descriptive statistics. The correlation between the MIDAS
and Numeric Pain Scale prior to implementation was compared to the correlation between
the MIDAS and Mankoski pain scale. The Doctor of Nursing Practice student and a
university statistician completed the analysis.
Results
This DNP quality improvement project focused on transitioning the best evidencebased patient care into the current practice. This result section includes statistical analysis of
the pre and post data and information from the staff survey that was collected post
implementation. The total number of adult patients that met the sample criteria was 107
patients. Outcome measures gathered for pre-implementation data came from 51 patients
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obtained through a chart audit generated by information technology personnel of the
organization. The post –implementation data came from 56 patients obtained through onsite
EHR review.
Sample Description and Correlation Analysis
A total of 107 patient encounters were included in the project population. In 2018,
51 patients presented with a diagnosis of headache. In 2019, 56 patients presented with a
diagnosis of headache. As shown in Table 1, the 2019 group had fewer men compared to
2018 group. Otherwise, sample characteristics of the two groups are very similar.
Table 1
Sample Characteristics
Group

Pre-Implementation
N=51

Post-Implementation
N=56

Sex

Male =10 (19.6%)

Male=5(8.9%)

Female =41(80.3%)

Female =51 (91%)

Range: 19-71

Range: 21-77

Mean: 41.43

Mean: 43.48

Age

Pre and Post-Implementation groups also were compared for diagnoses. In the 2018
group, most patients had a diagnosis of chronic migraine headache without aura (n=41,
80%). Other diagnoses were migraine, unspecified, not intractable, without status
migrainosus (n=7, 14%), and occipital neuralgia (n=3, 6%). In the 2019 group, most patients
had a diagnosis of chronic migraine headache without aura (n=42, 75%). Other diagnoses
were migraine, unspecified, not intractable, without status migrainosus (n=6, 11%), cluster
headache syndrome, unspecified, not intractable (n=2, 2%), other headache syndrome (n=3,
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3%), migraine unspecified, not intractable with status migrainosus, cervicalgia, and tensiontype headache (1, 2%).
Both groups were compared on the MIDAS functional rating and pain scale as
shown in Table 2. On average, the 2019 group were less severely debilitated in their
functionality, and had lower pain intensity levels.
Table 2
Pain and MIDAS Score Comparison
Group

Pre-Implementation
(2018-Group)

Post-Implementation
(2019-Group)

Range

Mean

Range

Mean

MIDAS Functional

0-75

23.6

0-90

12.6

Pain Scale Score

3-10

6.5

2-9

5.4

The pain and functional status were correlated using a Pearson’s correlation. These
ordinal level scales were treated as interval level data. In 2018 the correlation between
MIDAS and Numerical Pain Scale was 0.11177 (p=0.4349). In 2019, the correlation
between the MIDAS and Mankoski was 0.50360 (p=0.0001). The figure illustrates the
correlation between the MIDAS and pain scale, with the MIDAS and Mankoski
demonstrating the better linear fit. The Mankoski clearly better assesses the relationship
between function and pain.
Figure 1. Scatter Plot of MIDAS score Plotted Against Pain Scale
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Figure1: Scatter Plot of MIDAS score plotted against pain Scales. 2018 group
representing correlation between MIDAS score and Numeric Pain Scale,2019 group
representing correlation between MIDAS and Mankoski Pain Scale.
Staff Survey Results- Post Implementation
The post implementation staff survey included three Likert format questions to
obtain feedback regarding the pain assessment tool and the process of the change. The scale
ranged from “ agree” to “disagree.” As mentioned above there were five total clinical staff
(one neurologist, one nurse practitioner, one registered nurse and two medical assistants)
who were involved in the implementation process. Project champions and staff that were
involved in the process of this quality improvement project were given the survey (see
Appendix I). All staff (n=5, 100%) agreed that the change was easy to implement and
helpful. The staff survey indicated that the staff generally liked the Mankoski scale with the
possible exception of the third column, which asked for medications and narcotic usage. The
providers found that patients often identified their pain level based on the medication they
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used or that they preferred to have prescribed. The opioid crisis has made patients and
clinicians especially sensitive to narcotic options when it comes to pain management. So the
providers stated that the columns that simply described the effect of pain and the associated
number were sufficient.
Intervention and Approach
The intervention for this quality improvement project was the implementation of an
evidenced -based pain assessment tool to improve accuracy of the functional in a Headache
Clinic. The strategy of the implementation was built on communicating a vision for the
project outcome. Empowered stakeholders during the project implementation process
communicated via email and in face-to-face meetings every week and observed the process.
They found it efficient without major flaws. The stakeholders answered any and all
questions that were raised during the practice change process.
The stakeholders elicited patients’ feedback and followed their assessment to help
create a quick win through the patients’ experience. This feedback helped to connect the
stakeholders to help build the practice change and maintain their awareness of the amount of
progress they had made. The PARiHS framework was utilized to promote and facilitate
successful implementation through its three elements – context, process and facilitation
(Kitson et al., 1998). Using this model ensured implementation of a more descriptive pain
scale with strong supporting evidence. The Mankoski Pain scale, a patient and provider
preferred pain scale, proved especially valuable within the context of the organization.
Ethical Considerations
An application for review and approval or exemption of this project was submitted
to the health care system’s Institutional Review Board and to XXXX University. Beyond
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further planning, no project activities commenced until the review was completed and Board
approval or exemption was granted. The purpose and scope of this project was limited to
evidenced based quality improvement. No patient identifiable information was collected. No
physical, social, psychological, legal, or economic threats to patients were associated with
this project. Given the context, the impact of the project posed minimal or no risk to
participants. The DNP student and other team members completed human subject protection
training via the Collaborative Institute Training Initiative even though no planned
interaction with patients took place. The project did not require informed consent since it is
a quality improvement implementation that utilized only existing EHR data without patient
identifiers (pain intensity rating and functional assessment).
Discussion
For this DNP quality improvement project the clinical question was: Does
implementation of a standardized and descriptive pain assessment tool, such as the
Mankoski, at a Neurology Headache Clinic in a Midwestern city improve accuracy of
MIDAS screening and practice outcomes for headache patients? The result of the study
indicated that using the Mankoski, an evidenced based pain assessment tool, while screening
each headache patients with the MIDAS at every visit can more accurately assess the
relationship between functional level and pain level than the previous measure. Statistical
analysis determined that the Mankoski and MIDAS used together to assess chronic pain
among headache patients showed a moderate correlation.
This result is very relevant to the practice and needs of the organization. It suggests
that this combination of measures increases patient and clinician communication in order to
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develop more correct and effective treatment plans. The project implementation has many
advantages. The project is very cost effective.
Before the implementation, the DNP student identified a readiness for the change
among the staff. All clinicians, including the MA, were very supportive of the project and
viewed it as an improvement in quality of care. A staff survey was administered at the end
of the implementation. The staff expressed satisfaction. The successful implementation
resulted in a positive outcome for both patients and the clinic system. According to surveys
and interviews, patients were satisfied with the more descriptive pain assessment tool that
assessed their chronic pain. High patient satisfaction is one of the strongly desired
characteristics for the organization.
Further, this evidenced based practice change might be sustainable through
reimbursement. It might be considered screening. The practice may explore billing based on
this.
Limitations
This study was limited in three major ways – staff, assessment ambiguity, and
Mankoski pain scale issues. This clinic experienced some staff changes during the project.
Historically, the clinic has had a stable staff and it was assumed that the study would be
supported by the same staff throughout its implementation. The clinic added one NP and
one MA to the team during the implementation. As a result, the DNP student needed to give
more individual education sessions to these staff than originally expected.
The second limitation is, even though the Mankoski pain scale was imbedded within
EHR and was available for staff to print, it was not possible to modify the MIDAS screening
tool to make it one document. Thus, staff needed to print two separate documents in order to
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properly assess patients. However, staff could also use the laminated copy of the Mankoski
Pain Scale that was placed in each patient’s rooms. The MA would administer the MIDAS
screening tool to the patients and then hand them the Mankoski pain scale to measure their
pain intensity. The pain intensity was documented into the EHR along with the functional
score, but as a separate score. Another issue developed during this process is that it was
unclear whether the charted pain rating was the Mankoski and not Numeric Pain Scale. In
order to make data collection clearer and fix this limitation, the DNP student educated staff
(two Mas) to add the letter “M” next to the pain intensity level for easy recognition when
the patient was screened with Mankoski Pain Scale.
Documentation required three scores. The first was the functional score. Second (A)
was the number of days the patient had a headache within the past 3 months (90 days). The
third (B) was the pain score that the DNP student asked for the letter M to be placed by the
intensity level. For example a patient would be marked as “MIDAS screening - 24, (A) 90,
(B) 6(M). This meant the functional score was 24, the number of days with a headache was
90, and the Mankoski pain intensity score was 6.
Finally, the Mankoski pain assessment tool itself represented a third limitation. Even
though the Mankoski Pain Scale has been shown to be more efficient than the Numerical
Pain Scale, it was written in a different time and it needs modification. In particular, the
third column description of medication use, including narcotics, represents an issue in light
of the opioid epidemic. During the initial educational session, the physician provider
expressed concern regarding the third column of the assessment tool, since it listed narcotic
medications. Not only might the patient assume these drugs should be prescribed, many of
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the listed drugs are out of date. The DNP student initially educated staff that the third
column is an important part of the pain assessment and not merely a recommendation.
On the post implementation staff survey, the staff responded “disagree” on the
question “patients understand the pain assessment tool better.” The most common rationales
for this response were “Patients immediately referred to the last column of the pain
assessment tool regarding narcotic use” and “Patients jumped immediately to think they
needed narcotics due to the description, when patients took the time to understand pain
ranking it seemed to help.” Patients and clinicians agreed that the pain assessment tool is
very adequate and helpful for assessment and development of a treatment plan. However,
the third column proved distracting to the process.
Implications for Practice
This Doctor of Nursing Practice quality improvement project has several
implications in regards to practice and quality of patient care. Currently the Neurology
Clinic does not have a sufficiently objective pain assessment tool even though the
organization deals with chronic pain on a daily basis. Furthermore, there is no standard
process of screening patients. For example, not every patient is screened with MIDAS on
every visit.
After implementation the patient ratings will more accurately describe patient pain.
The Mankoski improves patient provider communication, which should lead to improved
treatment planning. This more descriptive pain assessment tool is highly recommended for
future practice.
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Dissemination of Results
To disseminate the project outcome, the DNP student shared the result and outcome
of the project at the monthly departmentwide meeting on March 22, 2019. The DNP stated
that the quality improvement project represented a more objective and descriptive pain scale
with its significant positive outcome and practice implication. In discussing the benefit of
the project to the organization and patients, the DNP suggested making the change
permanent and possibly department wide. This quality improvement project will be
presented as part of the DNP student’s final defense in April. At this time, the DNP will be
inviting stakeholders and the general public. The DNP student will further disseminate these
project outcomes in professional journals and conferences. In the future, different DNP
students may choose to adapt the project to modify the Mankoski pain scale, specifically the
third column.
Reflections on Doctor of Nursing Practice Essentials
In order to graduate, all Doctor of Nursing Practice students must meet the
requirement of eight essential competencies (American Association of Colleges of Nursing
[AACN], 2006). These essentials serve as a foundation of competencies within advanced
nursing practice. All eight essentials Competencies were met during the quality
improvement project implementation process.
Essential I: Scientific Underpinnings for Practice
According to the AACN, all Doctor of Nursing Practice students learn how to
integrate nursing science, and knowledge from other disciplines, to enhance the delivery of
healthcare, evaluate outcomes, and create better practice change (AACN, 2006). This
essential was achieved via literature review on evidenced-based chronic pain assessment
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tools. In addition the DNP student used the Conceptual frameworks and theories to help
guide the development and implementation of the project. To assess the organization the
Burke and Litwin Model of Organizational Performance and Change was successfully
utilized. A SWOT analysis was completed. This is a foundational assessment model to
guide organizational diagnosis to highlight what can or cannot be done, and the possible
threats and opportunities. Determining the organization’s needs with the help of frameworks
aided the DNP student to implement a quality improvement project that was targeted to
meet the organization’s needs.
Essential II: Organizational and Systems Leadership
According to the American Association of Colleges of Nursing (AACN), leadership
within the organization and system is a vital characteristic to improve practice and build the
foundation of successful practice change. This essential is a guide on assessing an
organization and working towards creating a change in practice to improve patient care. The
DNP student fulfilled this essential through meeting with leaders and stakeholders of the
organization as well as communicating with the clinic managers, providers, and other staff
members. Furthermore, the DNP performed an organizational needs assessment in order to
demonstrate organizational and system leadership. Finally, the DNP demonstrated
leadership skills when the DNP student presented scholarly project outcome at the
department wide meeting.
Essential III: Clinical Scholarship and Analytical Methods
One of the important parts of the DNP quality improvement project is to convert the
research findings into the evidenced-based practice (AACN, 2006). This essential involves
utilizing analytic methods while completing the literature review to determine best practice
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and applying relevant findings for improvement of health care practice. These activities
demonstrate this essential achievement. The DNP student provided the best evidenced-based
practice recommendation. The DNP student used appropriate data collection and data
analytic procedures. The project outcome will improve quality of headache patient care
within the Neurology Clinic.
Essential IV: Information Systems Technology
This essential states that the DNP is skilled at Information Systems Technology. The
student used information systems technology when gathering data from the patient
electronic health records for this quality improvement project. The student worked closely
with information technology personnel to generate data reports and gain appropriate
aggregate data outcomes. This information was used in conjunction with the quality
improvement project and assured evidenced based practice based on previous studies.
Essential V: Advocacy for Health Care Policy
Health care policy at any level creates a framework to assist the ability to address
health care needs (AACN, 2006). The better health care policies will deliver high quality
health care services, while dysfunctional health care policies will impede the ability of the
organization to deliver patient care. This project was meant to improve health care policy
through the usage of an improved headache pain assessment tool. During the assessment,
the DNP analyzed the organization’s current policies and retained the data in safe and
private environments in order to assure compliance with Health Insurance Portability and
Accountability Act privacy policies. De-identification of patients was maintained
throughout data gathering. Advanced practice nurses were engaged in the process of policy
development and advocacy for good health care policy. The DNP examined pain
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assessment, patient assessment policies and organizational procedures.
Essential VI: Interprofessional Collaboration
During this project, the DNP took many advantages of interprofessional
collaboration and met with several professionals within the organization including the
neurologists, NPs, RNs, MAs, managers, researchers and quality improvement data
specialists. The IT personnel were also consulted in order to maintain access to information
systems. The DNP not only communicated with these professionals but also facilitated
communication among other professionals.
Essential VII: Clinical Prevention and Population Health
This essential states that the DNP needs to participate in the process of preventing
ailments and improving population health. This project focused mainly on improving patient
health outcomes through more valid pain scales to improve communication between patients
and clinicians. This project will prevent miscommunication, which could lead to adverse
health outcomes.
Essential VIII: Advanced Nursing Practice
This quality improvement project is focused on adults and older adults and
improving their pain management. Advanced Nursing Practice states that not only does the
DNP serve the community but continually seeks ways to improve serving the community.
Through the essentials of quality improvement, the DNP fulfilled the Advanced Nursing
Practice essential.

Conclusion
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An organizational assessment was completed at the Headache Clinic within a
Neurology Clinic in a Midwestern city. An organizational assessment determined that the
clinic was lacking the tools to properly assess chronic headache pain. The organization
needed to accurately screen headache patients concerning their functional status via MIDAS
screening tool. The culture of the organization clearly values quality improvement and
evidence-based patient centered care. Stakeholders were highly involved in the process of
changing this practice. They agreed that an evidenced based, descriptive and objective pain
assessment tool would increase quality of patient care and improve patient outcomes by
improving clear communication between patients and clinicians. Improved patient care,
outcomes, and satisfaction are essential goals of this large hospital organization.
A literature review was conducted. The research evidence for chronic pain suggested
a more descriptive, comparative pain scale is preferred by patients and clinicians. During
implementation pre and post data were obtained. The pre 2018 group data included MIDAS
scores with intensity level measurement with Numerical Pain Scale, and the 2019 data
collection included the modified version of the MIDAS where the Mankoski Pain Scale
replaced the Numerical Pain Scale. With fairly similar sample groups, the data result
indicated that the MIDAS and Mankoski Pain Scale had stronger correlation coefficient of
0.50360 (p=0.0001) compared to the MIDAS and Numerical Pain Scale correlation of 0.11
(p=0.4349).
Thus, the Mankoski is better at assessing the relationship between function and pain
intensity compared to Numerical Pain Scale and it is preferred by patients and clinicians.
The staff survey indicated that the staff generally liked the Mankoski Pain Scale with the
possible exception of the third column which asked for medications and narcotic usage. The
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opioid crisis has made patients and clinicians especially sensitive to narcotic options when it
comes to pain management.
The DNP student recommends that the clinic modify the pain scale in order to
eliminate the last column. This way the scale may be used safely without suggesting that
patients turn to opioids. The pain scale was developed many years ago before opioid use
became a major health issue. This column may be untenable in the 2019 health care
environment.
This quality improvement project supported the clinical question that the Mankoski
Scale is a more accurate pain assessment tool than Numeric Pain Scale. While there were
some issues with the Mankoski scale including questions referring to narcotic medication,
these issues can be better addressed when the scale is fully implemented in the clinic. The
DNP student understands that the limitation of the project is in the implementation;
however, there is a good reason to continue to modify and perfect the usage of the Mankoski
scale for these clinic patients. This quality improvement project had mutual benefit to the
DNP student and the selected organization. The DNP student became more competent and
developed leadership skills during the project implementation. The outcome of the project
indeed helped organization to improve the quality of patient care.
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Appendix A

48

ASSESSMENT OF HEADACHE PAIN AND ITS FUNCTIONAL CAPACITY

Appendix B
Burke & Litwin Model

Note: A model of organizational performance and change. Reprinted from “A Causal Model
of Organizational Performance and Change,” by W. W. Burke and G. H. Litwin, 1992,
Journal of Management, 18, 528. Copyright 1992 by Southern Management Association.
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Appendix C
Burke & Litwin Model: Transformational Factors

Note: A model of organizational performance and change. Reprinted from “A Causal
Model of Organizational Performance and Change,” by W. W. Burke and G. H. Litwin,
1992, Journal of Management, 18, 528. Copyright 1992 by Southern Management
Association.
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Appendix D
Burke & Litwin Model: Transactional Factors

Note: A model of organizational performance and change. Reprinted from “A Causal Model
of Organizational Performance and Change,” by W. W. Burke and G. H. Litwin, 1992,
Journal of Management, 18, 528. Copyright 1992 by Southern Management Association.
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Appendix E
SWOT Analysis of Headache Clinic
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Appendix F
Flow Diagram of Search Selection Process Using PRISMA

Included

Eligibility

Screening

Identification

PRISMA 2009 Flow Diagram
Additional studies identified later
through other sources
(n = 2)

Initial articles identified
using keywords in CINAHL,
PubMed, Cochrane, and
ScienceDirect
(n = 346)

# of duplicates and duplicate dataset and
studies that did not mentioned the pain scale
removed
(n = 301)

Studies screened after
above exclusion removed
(n =47)

Each full-text articles were
screened including
exclusion criteria
according to the Prisma
criteria for eligibility
(n = 47 )

# of studies that did not
mentioned the pain scale
N=206
# of duplicates
N=68

# of duplicate dataset
N=27

Full-text articles excluded,
with reasons
(n = 24)

Studies included in
qualitative synthesis
(n = 23)
Studies included in this
literature review
(n = 10)

Note: Flow diagram of search selection process. Adapted from “Preferred reporting items
for systematic reviews and meta-analyses: The PRISMA statement,” by D. Moher, A.
Liberati, J. Tetzlaff, D. Altman, and PRISMA Group. Copyright 2009 by PLoS Medicine.
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Appendix G
Author (Year)
Purpose
Benz et al. (2017)
Health and
quality of life in
patients with
medication
overuse headache
syndrome
standardized
inpatient
rehabilitation

Benz et al.
(2018)
Translation,
crosss-cultural
adaptation
reliability of the

Literature Review Table of Evidence for Pain Scale
Design (N)
Inclusion
Intervention
Results
Criteria
vs
Comparison
Observatio
nal Crosssectional
pilot study.
Several
scales
including
MIDAS.
Questionna
ires

Diagnosis of
medication
overuse

Conclusion

Intervention

Moderate to high
levels of pain were
reported from
patients who came
off their
medication.
Physical function
was not different.

The MIDAS scale is
useful in regards to
assessing the MOH
severity during
withdrawal.

Comparison

MIDAS was
translated into
German and then
assessed using the
same criteria that it
was assessed for in
the English

The German version
is a short 7 item
condition-specific
questionnaire with
challenging phrasing
but practical
assessment that takes

headache
(MOH),
confirmed by
board
certified
neurologists.
Exclusion:
Subjects must
not have
serious
psychiatric
comorbidity,
benzodiazepin
e abuse,
severe
somatic
illness,
cancer,
inflammatory
rheumatic
disease or
serious
neurological
diseases

Test-retest
reliability

Patients at the
Rehabilitation
clinic in Bad
Zurzach,
Switzerland
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German version
of the migraine
disability
assessment
(MIDAS)
questionnaire
Zandifar et al.
(2014)

language.

less than five minutes
to fill out. It is a
highly reliable
instrument.

Test-retest
reliability

All subjects
were selected
from 4
neurology
clinics in
Isfahan, Iran.

Comparison

HIT-6 was assessed
by comparing
psychometric
properties as well
as testing and
retesting.

Validity and
reliability has been
established and
reinforced by this
study.

Cheatham et al.
(2018)
Concurrent
validity of pain
scales in
individuals with
myofascial pain
and fibromyalgia.

Validity
Study,
clinical
trial

Individuals
with
myofascial
pain (N=30)
and
fibromyalgia
(N=30)

Comparison

Individuals went
through two
different testing
points a week apart
from each other
with the different
pain assessments.
Numeric Pain
Scale, Visual
Analog Scale were
both used and
compared. They
were found to have
similar standards

According to this
study, numeric pain
scale has validity.

Mandysova et al.
(2017). A
comparison of
three self-report
pain scales in
Czech patients

Crosssectional

Hospitalized
Patients who
had
experienced
strokes

Comparison

Patients reported
their pain using
Numerical Rating
Scale, FACES Pain
Scale – Revised and
a combination of
Visual Analogue

This study showed
that the pain scales
were equivalent and
that patients preferred
the numeric pain
scale.

Reliability and
validity of the
Persian HIT-6
questionnaire in
migraine and
tension-type
headache.
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with stroke

Manworren &
Stinson (2016)

Scale and
Numerical Rating
Scale. There was a
strong correlation
between the pain
scales
Assessment Self-report
and
pain tools
Evaluation

Comparison

Authors state that
out of the 30
available self-report
pain intensity
measures, only 6
have wellestablished
psychometric
properties –
evidence, validity,
clinical utility and
feasibility.

No single pain scale
is reliable and valid
across all pediatric
ages; however,
certain tests are better
for certain age
groups. The authors
endorsed
Individualized
numeric rating scale
for children ages 6-18
with severe
intellectual
disabilities.

Kindelan-Calvo
et al (2014).
Effectiveness of
Therapeutic
Patient Education
for Adults with
Migraine.

A
Systematic
Review
and MetaAnalysis of
Randomize
d
Controlled
Trials

Studies on
patients with
migraines

Comparison

Analysis of
randomized control
trials (RCT) and
their effectiveness.
Fourteen RCTs
were studied

strong-moderate
evidence for
intermediate-term
effectiveness of
therapeutic patient
education for
migraine. Further
high-quality RCTs
are required for
conclusive
determination of its
effectiveness
(Kindelan-Calvo
2014, p. 1919).

Cady et al (2008)

Multivariable
study with
3 variable
groups and
one control

Patients with
migraines

Intervention

Three groups of
patients were given
a CD-Rom to view
with a nurse. The
nurse in the first
group could answer
questions. The

The educational CDRom was useful for
patient education.

Pediatric pain
measurement,
assessment and
evaluation.

Nurse based
education: Model
for teaching
migraines

Intervention

56

ASSESSMENT OF HEADACHE PAIN AND ITS FUNCTIONAL CAPACITY

second group nurse
had indepth
knowledge. The
third group nurse
did not explain. The
fourth group was
the control. Patients
were asked to fill
out surveys
concerning their
education.
Herford et al.
(2010) Use of
porcine collagen
matrix as an
alternative to
grafting oral soft
tissue defects

Qualitative
analysis

Patients who
underwent
intraoral
grafting to
recreate soft
tissue.

Comparison

Patients who had
parts of their
mouths removed
received porcine
collagen matrix
instead of soft
tissue grafts

Mankoski was used
for pain scale and
patients were found
to be more
comfortable. Primary
importance is the use
of Mankoski.

Douglas et al
(2013)
Determining pain
scale preference
in a veteran
population

Descriptive
correlation
al
comparativ
e design.

Veterans
(N=200) with
chronic pain
receiving
treatment in a
residential
rehabilitation
treatment
program.

Comparison

Research questions
designed to guide
the subjects into
stating their
preference between
four different pain
scales.

The majority
preferred Mankoski
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Appendix H
MIDAS

Note: Migrain Disability Assessment . Reprinted from “Development and testing of the
Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related
disability” by Stewart et al.(2001). Journal of Neurology,56,1.
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Appendix I
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Appendix J
Kotter Model of Change

Note: Adapted from “Kotter’s 8-Step Process”, by J. Kotter. Copyright 2017 by Kotter
International
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Appendix K
Implementation Presentation at Project Site

Intervention to Improve
Assessment of Headache
Pain and its Functional
Capacity
at Mercy Health
Hauenstein Neuroscience
Headache Clinic

Objectives for the Presentation
1. Background of the clinical problem
2. Review the organizational assessment
3. Review the evidence-based solution
4. Data collection and Implementation
5. Result

DNP Project Presentation
March 22nd 2019
Mavjuda (Judy ) Saydazamova, BSN, RN

Descriptive Pain Assessment Tool
Solution:

Background:

Headache
• One of the 10 most
disabling
condition

•

It is challenging to
properly assess in
clinical practice

•

•

The Issue :
•

• Chronic headache
pain is not
measured
accurately with
Numerical Pain
Scale
• Highly subjective

Literature supports to
replace Numerical Pain
Scale tool to more
descriptive, Mankoski
Pain Scale.
The pain scale uses both
words and numbers to
describe the pain
ratings from “0” to “10”
Each number on the
line has a description

Data Collection:

Scales to Measure
Pain

• Pre and Post implementation
data from EHR
• Mankoski Pain scale within
MIDAS screening vs
Numerical pain scale

Scales to Measure Pain

Numeric Pain Scale.

• Numeric Pain Scale.
- The pain scale is a single, 11-point numeric
scale
- Higher scores indicate greater pain intensity
- The patient is asked to rate pain on a 0-10
scale with “0” being no pain and “10” the
worst
- Can be highly subjective.
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Scales to Measure Pain
• Mankoski Pain Scale
– Developed by Andrea Mankoski, a patient who suffered from
endometriosis
– The pain scale uses both words and numbers to describe the pain
ratings from “0” to “10”
– Each number on the line has a description
– Allows the patient to give a more complete picture of his/her
pain intensity by using words instead of just numbers
– Better communication
– Scale was preferred by the patients
– Demonstrated test–retest reliability of (r =0.69, p < .001)
Palmer, 2014).

Scale is more objective and descriptive

Mankoski Pain Scale

(Douglas, Randleman, DeLane &

Scales to Measure Pain
• Migraine Disability Assessment (MIDAS) Tool
– Questionnaire assesses the impact of headache on functioning
– Helps to determine the best treatment option
– Comprehensive functional scale based on long term effects of the
headache
– Quantifies the disability associated with headaches over a threemonth time frame
– Determine how severely headaches affect a patient's life
– Has two independent parts
• Part one consists of five questions
• Part two is (A and B) to collect information on the frequency of
headaches and the intensity of the headache pain
• Uses the Numeric Pain Scale of 0-10

Clinical Practice Question
Does implementation of the standardized and
descriptive headache assessment tool, the
Mankoski, at Mercy Health Neurology
Headache Clinic improve accuracy of the
MIDAS screening tool?

(Zandifar et al., 2014).
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Change is
Difficult,
not
Changing
is Fatal

Result

Table of group by Gender
group

Table of group by ICD 10 code

Table of group by Gender
Gender(Gender)

Table of group by ICD_10

Frequency
Percent
Row Pct
Col Pct

group
Frequency
Percent
Row Pct
Col Pct

male

female

Total

2018

10
9.35
19.61
66.67

41
38.32
80.39
44.57

51
47.66

2018

2019

5
4.67
8.93
33.33

51
47.66
91.07
55.43

56
52.34

Total

15
14.02

92
85.98

107
100.00

ICD_10(ICD_10)

G43.709
41
38.32
80.39
49.40

G43.909
7
6.54
13.73
53.85

G44.009
0
0.00
0.00
0.00

M54.81
3
2.80
5.88
100.00

G43.901
0
0.00
0.00
0.00

M54.2
0
0.00
0.00
0.00

G44.89
0
0.00
0.00
0.00

G44.209
0
0.00
0.00
0.00

Total
51
47.66

2019

42
39.25
75.00
50.60

6
5.61
10.71
46.15

2
1.87
3.57
100.00

0
0.00
0.00
0.00

1
0.93
1.79
100.00

1
0.93
1.79
100.00

3
2.80
5.36
100.00

1
0.93
1.79
100.00

56
52.34

Total

83
77.57

13
12.15

2
1.87

3
2.80

1
0.93

1
0.93

3
2.80

1
107
0.93 100.00
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group
2018

2019

N
Obs Variable
51 Age
Pain
MIDAS
56 Age
Pain
MIDAS

N
Label
N Miss
Age
51
0
Pain
51
0
MIDAS 51
0

Mean
41.43
6.49
23.65

Age
56
Pain
56
MIDAS 56

43.48
5.41
12.63

0
0
0

Std
Median Dev Minimum Maximum
39.00 13.46
19.00
71.00
6.00 1.62
3.00
10.00
16.00 20.67
0.00
75.00
40.00 13.71
5.00 1.67
9.00 15.81

21.00
2.00
0.00

77.00
9.00
90.00

Lower
Quartile
29.00
5.00
6.00

Upper
Quartile
53.00
8.00
40.00

33.00
4.50
3.00

53.00
6.00
15.00

Checking Correlations
Group 2018
Pearson Correlation Coefficients, N = 51
Prob > |r| under H0: Rho=0
MIDAS
MIDAS
Numeric Pain
Numeric Pain

MIDAS
1.00000

Pain
0.11177
0.4349

0.11177
0.4349

1.00000

Group 2018- Age range 19-71 –mean of 41.43
This correlation was found to be
insignificant with a
p= .4349

Group 2019 - Age range 21-77- mean of 43.48

Checking Correlations
Group 2019

MIDAS
MIDAS
Pain
Pain

Pearson Correlation Coefficients, N = 56
Prob > |r| under H0: Rho=0
MIDAS
1.00000

Pain
0.50360
<.0001
1.00000

0.50360
<.0001

This correlation was found to be
significant with a p= <.0001

Dr. Bostrom
Dr. Burritt,K
Susan Price
Crystal Roets
IT team

My Project Champions
Emily Johnson
Angela Ceru
Very special Thanks
Sara Dykema
My most favorite MAs
Amy and Kathy
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Appendix L
Resources & Budget
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Appendix M
Permission for Copyrighted Materials
Approval to Use Kotter Model of Change Figure
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Approval of Use for Burke-Litwin Model Figure
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